Home › PTAB Cases › IPR2024-00631

Apotex Inc. et al. vs. Novo Nordisk A/S

Explore the PTAB proceeding IPR2024-00631 filed by Apotex Inc. et al. on 2024-03-01. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2024-00631

Filing Date

2024-03-01

Accorded Filing Date

2024-03-01

Institution Decision Date

2024-09-11

Last Modified Date

2025-01-10

Proceeding Type

IPR

Termination Date

2025-01-10

Trial Status

Terminated-Settled

Parties & Counsel

Petitioner

Apotex Inc. et al.

Represented By

Molenda, Johnet al

Patent Owner / Respondent

Novo Nordisk A/S

Represented By

Baughman, Jonet al

Tribunal & Venue

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1600 - Biotechnology & Organic Chemistry

Patent Information

1 Patent Involved

Respondent Application Number 15656042

Respondent Patent Number 10335462

External Links

Espacenet

Google Patents

Respondent Inventor Christine Bjoern Jensen

Respondent Tech Center TC 1600 - Biotechnology & Organic Chemistry

Address and Attorney/Agent Information

5 Registered Practitioners

Power of Attorney & Correspondence

Firm / Entity Name NOVO NORDISK INC. - INTELLECTUAL PROPERTY DEPARTMENT

Customer Number 23650

Address 800 Scudders Mill Road, Plainsboro, NJ, 08536, UNITED STATES

Attorney / Agent Information

Reg #	Name	Phone
56129	Wesley Nicolas	609-786-5418
62124	Leon Lum	609-786-4172
63996	Elizabeth Dingess-Hammond	317-433-3689
64519	Jianjie Hu	609-786-4129
74995	Kathryn Jones	804-426-7196

Proceeding Documents

127

Termination Decision: Post-DI Settlement TERMINATE

2025-01-10 FILING PARTY: BOARD

Download

Order: Order on Motions to Expunge ORDER

2025-01-10 FILING PARTY: BOARD

Download

Order: On Protective Orders and Motions to Seal ORDER

2025-01-10 FILING PARTY: BOARD

Download

Apotex's Motion to Expunge MOTION

2024-11-15 FILING PARTY: PETITIONER

Download

[Redacted] Patent Owner's Reply to Petitioner's Reply to Patent Owner's Preliminary Response REPLYTOOPP

2024-09-18 FILING PARTY: PETITIONER

Download

Institution Decision: Granting Institution of Inter Partes Review 35 U.S.C. sec. 314 Granting Motion for Joinder 35 U.S.C. sec. 315c 37 C.F.R. sec. 42.122 OTHER

2024-09-11 FILING PARTY: BOARD

Download

Order: Conduct of the Proceeding 37 C.F.R. sec. 42.5 ORDER

2024-09-11 FILING PARTY: BOARD

Download

Patent Owner's Motion to Seal MOTION

2024-07-15 FILING PARTY: PATENT OWNER

Download

Redacted - Apotex's Reply to Patent Owner's Preliminary Response OTHER

2024-07-01 FILING PARTY: PETITIONER

Download

Redacted - Patent Owner's Preliminary Response OTHER

2024-07-01 FILING PARTY: PETITIONER

Download

Apotex's Third Motion to Seal OTHER

2024-07-01 FILING PARTY: PETITIONER

Download

2001

EX2001 - Docket Sheet from PTACTS, Mylan Pharms. Inc. v. Novo Nordisk A/S, IPR2023-00724 Exhibit

2024-06-12 FILING PARTY: PATENT OWNER

Download

2003

EX2003 - June 7, 2024 Joint Stipulation to Modify Due Dates 3, 4, 5, 6, 7 and 8, Mylan Pharms. Inc. v. Novo Nordisk A/S, IPR2023-00724, Paper 56 Exhibit

2024-06-12 FILING PARTY: PATENT OWNER

Download

2007

EX2007 - Excerpted Declaration of Michael J. Blaha, M.D., Mylan Pharms. Inc. v. Novo Nordisk A/S, IPR2023-00724, EX2055 Exhibit

2024-06-12 FILING PARTY: PATENT OWNER

Download

2004

EX2004 - Excerpted Patent Owner’s Response, Mylan Pharms. Inc. v. Novo Nordisk A/S, IPR2023-00724, Paper 30 Exhibit

2024-06-12 FILING PARTY: PATENT OWNER

Download

2012

EX2012 - Declaration of Sayem Osman Exhibit

2024-06-12 FILING PARTY: PATENT OWNER

Download

2011

EX2011 - Patent Exclusivity for N209637 (Semaglutide/Ozempic), Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations, U.S. Food & Drug Administration Exhibit

2024-06-12 FILING PARTY: PATENT OWNER

Download

2006

EX2006 - Excerpted Declaration of Robin S. Goland, M.D., Mylan Pharms. Inc. v. Novo Nordisk A/S, IPR2023-00724, EX2054 Exhibit

2024-06-12 FILING PARTY: PATENT OWNER

Download

2008

EX2008 - Excerpted Declaration of Christopher A. Vellturo, Ph.D., Mylan Pharms. Inc. v. Novo Nordisk A/S, IPR2023-00724, EX2300 Exhibit

2024-06-12 FILING PARTY: PATENT OWNER

Download

Patent Owner's Motion to Seal MOTION

2024-06-12 FILING PARTY: PATENT OWNER

Download

2005

EX2005 - Excerpted Declaration of George L. Bakris, M.D., Mylan Pharms. Inc. v. Novo Nordisk A/S, IPR2023-00724, EX2011 Exhibit

2024-06-12 FILING PARTY: PATENT OWNER

Download

2009

EX2009 - Excerpted Declaration of Patrick J. Sinko, Ph.D., Mylan Pharms. Inc. v. Novo Nordisk A/S, IPR2023-00724, EX2056 Exhibit

2024-06-12 FILING PARTY: PATENT OWNER

Download

2002

EX2002 - Joint Stipulation to Modify Due Dates 2, 3, 4, 5, 6, 7 and 8, Mylan Pharms. Inc. v. Novo Nordisk A/S, IPR2023-00724 Paper 47 Exhibit

2024-06-12 FILING PARTY: PATENT OWNER

Download

None

Apotex's Reply to Patent Owner's Opposition to Petitioner's Motion for JoinderION FOR JOINDE REPLY

2024-04-15 FILING PARTY: PETITIONER

Download

Apotex's Motion to Seal MOTION

2024-04-15 FILING PARTY: PETITIONER

Download

Redacted - Apotex's Reply to Patent Owner's Opposition to Petitioner's Motion for Joinder OTHER

2024-04-15 FILING PARTY: PETITIONER

Download

Redacted - Patent Owner's Opposition to Petitioner's Motion for Joinder (Paper No. 9) OTHER

2024-04-15 FILING PARTY: PETITIONER

Download

None

Apotex's Reply to Patent Owner's Opposition to Petitioner's Motion for Joinder REPLY

2024-04-15 FILING PARTY: PETITIONER

Download

Notice: Notice filing date accorded NOTICE

2024-03-12 FILING PARTY: BOARD

Download

3001

Exhibit 3001 Exhibit

2024-03-11 FILING PARTY: BOARD

Download

Patent Owner's Power of Attorney & Designation of Lead and Back-Up Counsel NOTICE

2024-03-06 FILING PARTY: PATENT OWNER

Download

Patent Owner's Mandatory Notices NOTICE

2024-03-06 FILING PARTY: PATENT OWNER

Download

1502